These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9502344)
1. Effects of isosorbide dinitrate on oxygen uptake kinetics in cardiac patients. Koike A; Yajima T; Koyama Y; Shimizu N; Kano H; Kobayashi K; Taniguchi K; Marumo F; Hiroe M Med Sci Sports Exerc; 1998 Feb; 30(2):190-4. PubMed ID: 9502344 [TBL] [Abstract][Full Text] [Related]
2. Effects of nicorandil on kinetics of oxygen uptake at the onset of exercise in patients with coronary artery disease. Koike A; Hiroe M; Yajima T; Adachi H; Shimizu N; Kano H; Sugimoto K; Miyahara Y; Korenaga M; Marumo F Am J Cardiol; 1995 Sep; 76(7):449-52. PubMed ID: 7653442 [TBL] [Abstract][Full Text] [Related]
3. Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease. Kasparian H; Wiener L; Duca PR; Gottlieb RS; Brest AN Am Heart J; 1975 Jul; 90(1):68-74. PubMed ID: 1094819 [TBL] [Abstract][Full Text] [Related]
4. Effects of isosorbide dinitrate on exercise capacity in cardiac patients--relationship between oxygen uptake responses and hemodynamic effects. Koike A; Itoh H; Doi M; Taniguchi K; Marumo F; Umehara I; Hiroe M Jpn Circ J; 1990 Dec; 54(12):1535-45. PubMed ID: 2127608 [TBL] [Abstract][Full Text] [Related]
5. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease. Glancy DL; Richter MA; Ellis EV; Johnson W Am J Med; 1977 Jan; 62(1):39-46. PubMed ID: 319662 [TBL] [Abstract][Full Text] [Related]
6. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients. Döring G J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180 [TBL] [Abstract][Full Text] [Related]
7. Effects of isosorbide dinitrate and hydralazine on regional metabolic responses to arm exercise in patients with heart failure. Wilson JR; Untereker W; Hirshfeld J Am J Cardiol; 1981 Nov; 48(5):934-8. PubMed ID: 7304441 [TBL] [Abstract][Full Text] [Related]
8. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure. Franciosa JA; Cohn JN Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762 [TBL] [Abstract][Full Text] [Related]
9. Effects of isosorbide dinitrate on electrocardiography, hemodynamics, and ventilation in patients with exercise-induced elevation of pulmonary artery wedge pressure. Jørgensen LH; Thaulow E; Refsum HE Clin Cardiol; 1999 Oct; 22(10):623-8. PubMed ID: 10526685 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of nitrate tolerance in patients with coronary heart disease by vascular ultrasonography and treadmill exercise. Yu GL; Zhuang HP; Wang ZH; Liao JT Int J Cardiol; 1999 May; 69(2):133-7. PubMed ID: 10549836 [TBL] [Abstract][Full Text] [Related]
11. Response to changing plasma concentrations of isosorbide-bound NO2 during acute and sustained treatment with isosorbide dinitrate in patients with coronary artery disease. Jørgensen LH; Thaulow E; Bredesen J; Refsum HE Clin Cardiol; 2000 Jun; 23(6):427-32. PubMed ID: 10875033 [TBL] [Abstract][Full Text] [Related]
12. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise. Wilson JR; Ferraro N Am J Med; 1981 Oct; 71(4):627-33. PubMed ID: 7282752 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of theophylline and isosorbide dinitrate on exercise capacity in stable angina pectoris, and their mechanisms of action. Crea F; Pupita G; Galassi AR; el-Tamimi H; Kaski JC; Davies GJ; Maseri A Am J Cardiol; 1989 Nov; 64(18):1098-102. PubMed ID: 2816761 [TBL] [Abstract][Full Text] [Related]
14. Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals. Barillà F; Pelliccia F; Valente A; Cianfrocca C; Romeo F; Reale A Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():905-8. PubMed ID: 2076398 [TBL] [Abstract][Full Text] [Related]
15. Effects of isosorbide dinitrate on the response to atrial pacing in coronary heart disease. Steele RJ; Burggraf GW; Parker JO Am J Cardiol; 1975 Aug; 36(2):206-10. PubMed ID: 1155342 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers. Noll G; Wenzel RR; de Marchi S; Shaw S; Lüscher TF Circulation; 1997 May; 95(9):2286-92. PubMed ID: 9142006 [TBL] [Abstract][Full Text] [Related]
17. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease. Neuhaus R; Johnen R; Vydra L; Solbach C Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899 [TBL] [Abstract][Full Text] [Related]
18. Effect of isosorbide dinitrate on submaximal exercise capacity of patients with chronic left ventricular failure. Wilson JR; Ferraro N Chest; 1982 Dec; 82(6):701-4. PubMed ID: 7140397 [TBL] [Abstract][Full Text] [Related]
19. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris. Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136 [TBL] [Abstract][Full Text] [Related]
20. The antianginal efficacy of isosorbide dinitrate therapy is maintained during diuretic treatment. Sussex BA; Campbell NR; Raju MK; McKay DW Clin Pharmacol Ther; 1994 Aug; 56(2):229-34. PubMed ID: 8062500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]